HayabuchiN,ShibamotoY,OnizukaY.,,1999,Primary central nervous system lymphoma in Japan: a nationwide survey,Int J Radiat Oncol Biol Phys,44,265,72
FerreriAJ,MarturanoE. Primary CNS,,2012,,Best Pract Res Clin Haematol,25,119,30
DeAngelisLM,YahalomJ,HeinemannMH,CirrincioneC,ThalerHT,KrolG,,1990,Primary CNS lymphoma: combined treatment with chemotherapy and radiotherapy,Neurology,40,80,6
FerreriAJ,Dell'OroS,FoppoliM,BernardiM,BrandesAA,TosoniA,,2006,MATILDE regimen followed by radiotherapy is an active strategy against primary CNS lymphomas,Neurology,66,1435,8
FerreriAJ,CiceriF,BrandesAA,MontanariM,BalzarottiM,SpinaM,,2014,MATILDE chemotherapy regimen for primary CNS lymphoma: results at a median follow-up of 12 years,,82,1370,3
SonodaY,MatsumotoK,KakutoY,NishinoY,KumabeT,TominagaT,,2007,Primary CNS lymphoma treated with combined intra-arterial ACNU and radiotherapy,Acta Neurochir (Wien),149,1183,9
GhesquieresH,FerlayC,SebbanC,PerolD,BoslyA,CasasnovasO,,2010,Long-term follow-up of an age-adapted C5R protocol followed by radiotherapy in 99 newly diagnosed primary CNS lymphomas: a prospective multicentric phase II study of the Groupe d'Etude des Lymphomes de l'Adulte (GELA),Ann Oncol,21,842,50
MorrisPG,CorreaDD,YahalomJ,RaizerJJ,SchiffD,GrantB,,2013,Rituximab, methotrexate, procarbazine, and vincristine followed by consolidation reduced-dose whole-brain radiotherapy and cytarabine in newly diagnosed primary CNS lymphoma: final results and long-term outcome,J Clin Oncol,31,3971,9
HironoS,IwadateY,HiguchiY,SerizawaT,NaganoO,MatsutaniT,,2015,Stereotactic radiosurgery in combination with up-front highdose methotrexate as a first-line treatment for newly diagnosed primary central nervous system lymphoma,J Neurooncol,123,237,44
FerreriAJ,CwynarskiK,PulczynskiE,PonzoniM,DeckertM,PolitiLS,,2016,phase 2 trial,The Lancet Haematology,3,e217,e27
Alvarez-PinzonAM,WolfAL,SwedbergH,CoySR,ValerioJE,,2016,Primary Central Nervous System Lymphoma (PCNSL): Analysis of Treatment by Gamma Knife Radiosurgery and Chemotherapy in a Prospective, Observational Study,Cureus,8,e697,
CloneyMB,SonabendAM,YunJ,YangJ,IwamotoF,SinghS,,2017,The safety of resection for primary central nervous system lymphoma: a single institution retrospective analysis,J Neurooncol,132,189,97
OstromQT,BauchetL,DavisFG,DeltourI,FisherJL,LangerCE,,2014,The epidemiology of glioma in adults: a "state of the science" review,Neuro-oncology,,,
Ahsan J, Hashmi SN, Muhammad I, Din HU, Butt AM, Nazir S, et al.
Spectrum of central nervous system tumours-a single center
histopathological review of 761 cases over 5 years. J Ayub Med
Coll Abbottabad. 2015; 27: 81-4.
Goebel S, Stark A, Kaup L, Von Harscher M, Mehdorn H. Distress in
patients with newly diagnosed brain tumours. Psycho-Oncology.
2011; 20: 623-30.
PetruzziA,FinocchiaroCY,LampertiE,SalmaggiA,,2013,Living with a brain tumor,Support Care in Cancer,21,1105,11
Rooney AG, Brown PD, Reijneveld JC, Grant R. Depression in
glioma: a primer for clinicians and researchers. J Neurol Neurosurg
Psychiatry. 2014; 85: 230-5. doi: 10.1136/jnnp-2013-306497
Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P.
Depression and functional outcome in patients with brain tumors:
a population-based 1-year follow-up study. J Neurosurg. 2005 103: 841-7.
Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P.
Depression and functional outcome in patients with brain tumors:
a population-based 1-year follow-up study. J Neurosurg. 2005 103: 841-7.
Rooney AG, McNamara S, MacKinnon M, Fraser M, Rampling R,
Carson A, et al. The frequency, longitudinal course, clinical
associations, and causes of emotional distress during primary
treatment of cerebral glioma. Neuro-Oncol 2013; 15: 635-43. doi:
10.1093/neuonc/not009..
Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA,
Quinn HE, et al. Evaluation and characterization of generalized
anxiety and depression in patients with primary brain tumors.
Neuro-Oncol 2008; 10: 171-81.
Satin JR, Linden W, Phillips MJ. Depression as a predictor of
disease progression and mortality in cancer patients. Cancer.
2009; 115: 5349-61.
Rahman Z, Wong C, Dexter M, Olsson G, Wong M, Gebsky V, et
al. Epilepsy in patients with primary brain tumors: the impact
on mood, cognition, and HRQOL. Epilepsy & Behav. 2015; 48:
88-95.
Armstrong TS, Ying Y, Wu J, Acquaye AA, Vera-Bolanos E, Gilbert
MR, et al. The relationship between corticosteroids and symptoms
in patients with primary brain tumors: utility of the
Dexamethasone Symptom Questionnaire-Chronic. Neuro-Oncol.
2015; 11: 114-20
Walbert T, Khan M. End-of-life symptoms and care in patients with
primary malignant brain tumors: a systematic literature review. J
Neuro-Oncology. 2014; 117: 217-24.
OstromQT,BauchetL,DavisFG,DeltourI,FisherJL,LangerCE,,2014,The epidemiology of glioma in adults: a "state of the science" review,Neuro-oncology,,,
Ahsan J, Hashmi SN, Muhammad I, Din HU, Butt AM, Nazir S, et al.
Spectrum of central nervous system tumours-a single center
histopathological review of 761 cases over 5 years. J Ayub Med
Coll Abbottabad. 2015; 27: 81-4.
Goebel S, Stark A, Kaup L, Von Harscher M, Mehdorn H. Distress in
patients with newly diagnosed brain tumours. Psycho-Oncology.
2011; 20: 623-30.
PetruzziA,FinocchiaroCY,LampertiE,SalmaggiA,,2013,Living with a brain tumor,Support Care in Cancer,21,1105,11
Rooney AG, Brown PD, Reijneveld JC, Grant R. Depression in
glioma: a primer for clinicians and researchers. J Neurol Neurosurg
Psychiatry. 2014; 85: 230-5. doi: 10.1136/jnnp-2013-306497
Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P.
Depression and functional outcome in patients with brain tumors:
a population-based 1-year follow-up study. J Neurosurg. 2005 103: 841-7.
Mainio A, Hakko H, Niemelä A, Koivukangas J, Räsänen P.
Depression and functional outcome in patients with brain tumors:
a population-based 1-year follow-up study. J Neurosurg. 2005 103: 841-7.
Rooney AG, McNamara S, MacKinnon M, Fraser M, Rampling R,
Carson A, et al. The frequency, longitudinal course, clinical
associations, and causes of emotional distress during primary
treatment of cerebral glioma. Neuro-Oncol 2013; 15: 635-43. doi:
10.1093/neuonc/not009..
Arnold SD, Forman LM, Brigidi BD, Carter KE, Schweitzer HA,
Quinn HE, et al. Evaluation and characterization of generalized
anxiety and depression in patients with primary brain tumors.
Neuro-Oncol 2008; 10: 171-81.
Satin JR, Linden W, Phillips MJ. Depression as a predictor of
disease progression and mortality in cancer patients. Cancer.
2009; 115: 5349-61.
Rahman Z, Wong C, Dexter M, Olsson G, Wong M, Gebsky V, et
al. Epilepsy in patients with primary brain tumors: the impact
on mood, cognition, and HRQOL. Epilepsy & Behav. 2015; 48:
88-95.
Armstrong TS, Ying Y, Wu J, Acquaye AA, Vera-Bolanos E, Gilbert
MR, et al. The relationship between corticosteroids and symptoms
in patients with primary brain tumors: utility of the
Dexamethasone Symptom Questionnaire-Chronic. Neuro-Oncol.
2015; 11: 114-20
Walbert T, Khan M. End-of-life symptoms and care in patients with
primary malignant brain tumors: a systematic literature review. J
Neuro-Oncology. 2014; 117: 217-24.